Status:
COMPLETED
Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the antidepressant efficacy, safety, and tolerability of DVS-SR in subjects receiving daily doses of 50 mg or 100 mg of DVS-SR versus subjects receiving placebo...
Eligibility Criteria
Inclusion
- Clinical diagnosis of major depressive disorder
- Must be able to swallow tablets
- Must be at least 18 years of age.
Exclusion
- Clinical diagnosis of other psychiatric disorders
- Significant risk of suicide
- Unstable medical conditions.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT00277823
Start Date
February 1 2006
End Date
January 1 2007
Last Update
December 28 2007
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Beverly Hills, California, United States, 90210
2
Northridge, California, United States, 91324
3
Farmington, Connecticut, United States, 06030
4
Washington D.C., District of Columbia, United States, 20037